Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00750958 · ClinicalTrials.gov registry record · NA
PREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuard
A NA study of Cardiac Event, sponsored by Datascope Patient Monitoring.
- Completed
- Registry status
- NA
- Development phase
- 287
- Enrollment target
- 2
- Study locations
NCT00750958 is a NA study of Cardiac Event that has completed, run by Datascope Patient Monitoring. The registered enrollment target is 287 participants, below the 993-participant average among 3 other Cardiac Event trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00750958, a NA study of Cardiac Event, has completed, sponsored by Datascope Patient Monitoring.
- COMPLETED
- Registry status
- NA
- Development phase
- 287 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the incidence of clinically significant rhythm and rate changes in ED patients who are not placed on conventional telemetry, and to test the user-friendliness of a automated clinician alter device in hectic and noisy setting of a busy emergency room.
Conditions Studied
Interventions
- PROCEDURE NetGuard Automated Clinician Alert System
Study Locations (2)
Pennsylvania
- Dr Charles Pollack - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00750958
The ClinicalTrials.gov registry entry for NCT00750958 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 993-participant average among 3 other Cardiac Event trials with a reported enrollment target (71% lower). The listed sponsor is Datascope Patient Monitoring, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Event appearing as the primary indexed condition, and to 1 intervention - of which NetGuard Automated Clinician Alert System is the first listed.
NCT00750958 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00750958 about?
NCT00750958 is a clinical study titled "PREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuard". The purpose of this study is to determine the incidence of clinically significant rhythm and rate changes in ED patients who are not placed on conventional telemetry, and to test the user-friendliness of a automated clinician alter device in hectic and noisy setting of a busy emergency room.
What is the current status of trial NCT00750958?
This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2008-06. Estimated completion is 2008-07.
What conditions does trial NCT00750958 study?
This clinical trial studies the following conditions: Cardiac Event.
What interventions are being tested in trial NCT00750958?
The interventions under investigation include: NetGuard Automated Clinician Alert System (PROCEDURE).
Who is sponsoring clinical trial NCT00750958?
This trial is sponsored by Datascope Patient Monitoring, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00750958 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Event
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.